EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology Letters

Authors: Elisa Chiadini, Emanuela Scarpi, Alessandro Passardi, Daniele Calistri, Martina Valgiusti, Luca Saragoni, Wainer Zoli, Dino Amadori, Paola Ulivi Affiliations: Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) […]

Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncology

Luisa Foltran1,2, Giovanna De Maglio3, Nicoletta Pella1, Paola Ermacora1, Giuseppe Aprile1, Elena Masiero3, Mariella Giovannoni1, Emiliana Iaiza1, Giovanni Gerardo Cardellino1, Stefania Eufemia Lutrino1, Micol Mazzer1,4, Manuela Giangreco5, Federica Edith Pisa5, Stefano Pizzolitto3 & Gianpiero Fasola1 1Department of Oncology, University Hospital ‘S Maria della Misericordia’, Piazzale S Maria della Misericordia 15, Udine, Italy 2Department of Oncology, […]

P2X7 mRNA expression in non?small cell lung cancer: MicroRNA regulation and prognostic value. Oncology Letters

Authors: Laura Boldrini, Mirella Giordano, Greta Alì, Franca Melfi, Gaetano Romano, Marco Lucchi, Gabriella Fontanini Affiliations: Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa 56126, Italy, Unit of Pathological Anatomy III, University Hospital of Pisa, Pisa 56126, Italy, Unit of Thoracic Surgery, University Hospital of Pisa, Pisa 56126, Italy. Abstract […]

Greta Alì, Agnese Proietti, Serena Pelliccioni, Cristina Niccoli, Cristiana Lupi, Elisa Sensi, Riccardo Giannini, Nicla Borrelli, Maura Menghi, Antonio Chella, Alessandro Ribechini, Federico Cappuzzo, Franca Melfi, Marco Lucchi, Alfredo Mussi, and Gabriella Fontanini (2014) ALK Rearrangement in a Large Series of Consecutive Non–Small Cell Lung Cancers: Comparison Between a New Immunohistochemical Approach and Fluorescence In Situ Hybridization for the Screening of Patients Eligible for Crizotinib Treatment. Archives of Pathology & Laboratory Medicine: November 2014, Vol. 138, No. 11, pp. 1449-1458.

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter